DMC Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$447K Sell
486
-156
-24% -$158K 0.3% 91
2025
Q4
$690K Sell
642
-93
-13% -$88.9K 0.46% 65
2025
Q3
$561K Buy
735
+28
+4% +$20.8K 0.39% 77
2025
Q2
$551K Sell
707
-65
-8% -$50.5K 0.43% 76
2025
Q1
$638K Sell
772
-60
-7% -$49.9K 0.52% 65
2024
Q4
$642K Sell
832
-242
-23% -$200K 0.52% 60
2024
Q3
$952K Sell
1,074
-143
-12% -$129K 0.77% 40
2024
Q2
$1.1M Sell
1,217
-298
-20% -$238K 0.94% 34
2024
Q1
$1.18M Sell
1,515
-5
-0.3% -$3.56K 1.02% 30
2023
Q4
$886K Sell
1,520
-250
-14% -$146K 0.84% 40
2023
Q3
$951K Sell
1,770
-276
-13% -$142K 0.89% 37
2023
Q2
$960K Sell
2,046
-101
-5% -$42.4K 0.96% 31
2023
Q1
$753K Sell
2,147
-60
-3% -$20.2K 0.76% 43
2022
Q4
$806K Sell
2,207
-80
-3% -$28.4K 0.91% 34
2022
Q3
$735K Sell
2,287
-261
-10% -$82.7K 0.89% 30
2022
Q2
$827K Buy
2,548
+298
+13% +$89.5K 0.98% 28
2022
Q1
$627K Sell
2,250
-624
-22% -$161K 0.7% 44
2021
Q4
$680K Buy
+2,874
New +$729K 0.59% 50

Other funds holding LLY

DMC Group's LLY Position: Q1 2026 in Review

DMC Group reduced its Eli Lilly (LLY) stake by 24% in Q1 2026, selling an estimated $158K and leaving 486 shares worth $447K. The position accounts for 0.3% of the portfolio, ranked #91.

DMC Group first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.18M in Q1 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • DMC Group held 486 shares of Eli Lilly worth $447K as of Q1 2026.
  • DMC Group sold 156 Eli Lilly shares in Q1 2026, an estimated $158K.
  • Eli Lilly made up 0.3% of DMC Group's portfolio in Q1 2026, its #91 holding.
  • DMC Group first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • DMC Group's Eli Lilly position peaked at $1.18M in Q1 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on DMC Group's 13F filing for Q1 2026, filed 30 Apr 2026.